 | |
| Company type | Public |
|---|---|
|
| |
| ISIN | GB0002074580  |
| Industry | Biotechnology |
| Founded | 1933 |
| Headquarters | Basingstoke, Hampshire, UK |
Key people | Iain Ferguson, Chairman[1] Jorgen Kokke, CEO[1] |
| Revenue |  £689.7 million (2023)[2] |
 £40.5 million (2023)[2] | |
| £31.8 million (2023)[2] | |
| Website | www |
Genus plc is a British-based business selling elite genetics and other products manufactured using biotechnologytocattle and pig farmers. It is headquartered in Basingstoke and is a constituent of the FTSE 250 Index.
The business has its origins in the former Breeding & Production Division of the Milk Marketing Board which was established in 1933 and broken up in 1994.[3] In 1999 Genus acquired ABS Global, a company founded by J.R. Prentice in the US as the American Breeders Service in 1941 selling the semenofcattle.[4] In 2005 Genus acquired, through the takeover of Sygen International plc, PIC, a company founded by six pork producers in the UK as the Pig Improvement Company in 1962.[5]
The company has three divisions:[6]
PIC's pedigree herds sire an estimated 30% of commercially reared pigs.[7]
|
| |||||
|---|---|---|---|---|---|
| |||||
| Companies |
| ||||
| Government and regulatory bodies |
| ||||
| Industry and professional bodies |
| ||||
| Books and journals |
| ||||
| Other |
| ||||
| |||||
|
| |
|---|---|
|
